Skip to main content
SpringerLink
Log in

Abemaciclib

Elevated bilirubin level: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cano KSV, et al. Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi). ESMO Open 8 (Suppl. 4): 37-38 abstr. 250P, No. 1, 13 May 2023. Available from: URL: http://doi.org/10.1016/j.esmoop.2023.101438 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abemaciclib. Reactions Weekly 1969, 16 (2023). https://doi.org/10.1007/s40278-023-44482-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44482-7

Search

Navigation